Literature DB >> 7681361

Dose-dependent recruitment of pancreatic acinar cells during receptor-mediated calcium mobilization.

P H Willems1, S E Van Emst-De Vries, C H Van Os, J J De Pont.   

Abstract

Digital-imaging microscopy of Fura-2-loaded rabbit pancreatic acinar cells was used to simultaneously monitor the cholecystokinin-octapeptide (CCK8)-induced changes in free cytosolic Ca2+ concentration, [Ca2+]i, in large numbers of individual acinar cells. CCK8 typically evoked a switchlike increase in [Ca2+]i which was preceded by a concentration-dependent latency. The threshold concentration for the CCK8-induced rise in [Ca2+]i differed greatly among individual acinar cells, resulting in the dose-dependent recruitment of acinar cells in terms of CCK8-induced Ca2+ mobilization. The EC50 value for CCK8-induced cell-recruitment was estimated to be 15 pM. The hormone was equally potent in stimulating amylase secretion from acinar cells in suspension. At a CCK8 concentration of 100 pM, virtually all cells responded to the hormone with an increase in [Ca2+]i and the number of responding cells remained unchanged upon further increase of the CCK8 concentration. The dose-response curve for cell-recruitment coincides with that of the apparent [Ca2+]i increase in a suspension of acinar cells. This suggests that the most likely interpretation of the latter dose-response curve is not a generalized increase in [Ca2+]i but an increase in the number of responding cells. The initial rise in [Ca2+]i, which was transient by nature, was followed by repetitive [Ca2+]i transients of long duration. The dose-response curve for the effect of CCK8 on the percentage of acinar cells displaying these distinct [Ca2+]i oscillations was biphasic. A maximum of 99% of the cells showing oscillatory behaviour was reached at 100 pM CCK8, beyond which concentration the number of oscillating cells dose-dependently decreased again. The latter decrease was paralleled by a dose-dependent increase of the percentage responding but non-oscillating cells, indicating that beyond 100 pM CCK8 an increasing number of acinar cells became desensitized towards hormonal induction of oscillatory changes in [Ca2+]i. CCK8 was approximately 100-fold more potent in reducing the percentage of oscillating cells than in inhibiting amylase secretion. Oscillating acinar cells responded to a stepwise increase of the medium CCK8 concentration with a rapid change in amplitude and frequency of the oscillations. Thus, with increasing CCK8 concentration the frequency gradually increased, whereas the amplitude only slightly increased at first, reached a maximum, and decreased thereafter. In some cells full extinction was reached. Again, large differences in dose-dependency were observed among individual acinar cells. The observations presented demonstrate the existence of a marked functional heterogeneity among pancreatic acinar cells in terms of CCK8-induced Ca2+ mobilization.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681361     DOI: 10.1016/0143-4160(93)90084-j

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  12 in total

1.  Receptor-evoked Ca2+ mobilization in pancreatic acinar cells: evidence for a regulatory role of protein kinase C by a mechanism involving the transition of high-affinity receptors to a low-affinity state.

Authors:  P H Willems; H J Van Hoof; M G Van Mackelenbergh; J G Hoenderop; S E Van Emst-De Vries; J J De Pont
Journal:  Pflugers Arch       Date:  1993-07       Impact factor: 3.657

2.  The linear C-terminal regions of epidermal growth factor (EGF) and transforming growth factor-alpha bind to different epitopes on the human EGF receptor.

Authors:  A E Lenferink; A D De Roos; M J Van Vugt; M L Van de Poll; E J Van Zoelen
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

3.  Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release.

Authors:  F J van Kuppeveld; J G Hoenderop; R L Smeets; P H Willems; H B Dijkman; J M Galama; W J Melchers
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

4.  The relationship between receptor-effector unit heterogeneity and the shape of the concentration-effect profile: pharmacodynamic implications.

Authors:  A Hoffman; A Goldberg
Journal:  J Pharmacokinet Biopharm       Date:  1994-12

5.  The development of a superfusion system for studying intracellular and secretory processes in embryos.

Authors:  H J Goverde; R H Peeters; P H Willems
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-12       Impact factor: 2.416

6.  Pharmacological evaluation of the role of cytochrome P450 in intracellular calcium signalling in rat pancreatic acinar cells.

Authors:  J I Bruce; A C Elliott
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

7.  Calcium imaging in intact mouse acinar cells in acute pancreas tissue slices.

Authors:  Urška Marolt; Eva Paradiž Leitgeb; Viljem Pohorec; Saška Lipovšek; Viktória Venglovecz; Eleonóra Gál; Attila Ébert; István Menyhárt; Stojan Potrč; Marko Gosak; Jurij Dolenšek; Andraž Stožer
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

8.  Cholecystokinin-stimulated enzyme secretion from dispersed rabbit pancreatic acinar cells: phosphorylation-dependent changes in potency and efficacy.

Authors:  P H Willems; S E Van Emst-de Vries; J J De Pont
Journal:  Pflugers Arch       Date:  1995-09       Impact factor: 3.657

9.  Ruthenium red selectively depletes inositol 1,4,5-trisphosphate-sensitive calcium stores in permeabilized rabbit pancreatic acinar cells.

Authors:  F H van de Put; J G Hoenderop; J J De Pont; P H Willems
Journal:  J Membr Biol       Date:  1993-08       Impact factor: 1.843

10.  Induction of Ca2+ oscillations by selective, U73122-mediated, depletion of inositol-trisphosphate-sensitive Ca2+ stores in rabbit pancreatic acinar cells.

Authors:  P H Willems; F H Van de Put; R Engbersen; R R Bosch; H J Van Hoof; J J de Pont
Journal:  Pflugers Arch       Date:  1994-06       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.